Has TIS management ever referred to the continuing progress of FDA approved competitor Apligraf in the treatment of chronic diabetic foot ulcers and venous leg ulcers ? I note that on August 4 the company obtained a 5 year contract to treat these conditions in the Veterans' Hospitals in the USA.
http://article.wn.com/view/2014/08/04/Organogenesis_Awarded_a_5Year_Federal_Supply_Schedule_Agreem/